Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris.
Lebwohl
Mark G
MG
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives; D003879:Dermatologic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; D009824:Ointments; C055085:calcipotriene; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D002117:Calcitriol